Cargando…

Hsa-MiR-590-3p Promotes the Malignancy Progression of Pancreatic Ductal Carcinoma by Inhibiting the Expression of p27 and PPP2R2A via G1/S Cell Cycle Pathway

OBJECTIVE: To investigate the effect of miR-590-3p on the malignant biological behavior of pancreatic cancer, and to explore the target genes and pathways directly affected by miR-590-3p, to provide new therapeutic ideas and targets for the study of the diagnosis and treatment of pancreatic cancer....

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Xiaoyang, Sheng, Weiwei, Jia, Chao, Tang, Jingtong, Dong, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605676/ https://www.ncbi.nlm.nih.gov/pubmed/33149617 http://dx.doi.org/10.2147/OTT.S260499

Ejemplares similares

hsa_circ_0010889 downregulation inhibits malignant glioma progression by modulating the miR-590-5p/SATB1 axis
por: Wu, Zhi, et al.
Publicado: (2023)

Elevated hsa‐miR‐590‐3p expression down‐regulates HMGB2 expression and contributes to the severity of IgA nephropathy
por: Zhai, Yaling, et al.
Publicado: (2019)

miR-590-5p Targets Skp2 to Inhibit the Growth and Invasion of Malignant Melanoma Cells
por: Tong, Yang, et al.
Publicado: (2022)

Hsa_circ_0001658 accelerates the progression of colorectal cancer through miR-590-5p/METTL3 regulatory axis
por: Lu, Yang, et al.
Publicado: (2023)

Circular RNA hsa_circ_0005114-miR-142-3p/miR-590-5p-adenomatous polyposis coli protein axis as a potential target for treatment of glioma
por: Wei, Bo, et al.
Publicado: (2021)

Hsa-miR-590-5p Interaction with SMAD3 Transcript Supports Its Regulatory Effect on The TGFβ Signaling Pathway
por: Jafarzadeh, Meisam, et al.
Publicado: (2016)

Expression Analysis of hsa-miR-181a-5p, hsa-miR-143-3p, hsa-miR-132-3p and hsa-miR-23a-3p as Biomarkers in Colorectal Cancer—Relationship to the Body Mass Index
por: Tesolato, Sofía Elena, et al.
Publicado: (2023)

miR-590-5p inhibits tumor growth in malignant melanoma by suppressing YAP1 expression
por: Mou, Kuanhou, et al.
Publicado: (2018)

Diagnostic Significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p Panel and Ratios in Hepatocellular Carcinoma on Top of Liver Cirrhosis in HCV-Infected Patients
por: Eldosoky, Mona A., et al.
Publicado: (2023)

CeRNA network identified hsa-miR-17-5p, hsa-miR-106a-5p and hsa-miR-2355-5p as potential diagnostic biomarkers for tuberculosis
por: Song, Jie, et al.
Publicado: (2023)

Long Non-coding MIR205HG Depletes Hsa-miR-590-3p Leading to Unrestrained Proliferation in Head and Neck Squamous Cell Carcinoma
por: Di Agostino, Silvia, et al.
Publicado: (2018)

Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis
por: Lin, Xiaoping, et al.
Publicado: (2016)

MED10 Drives the Oncogenicity and Refractory Phenotype of Bladder Urothelial Carcinoma Through the Upregulation of hsa-miR-590
por: Wu, Chia-Chang, et al.
Publicado: (2022)

hsa-miR-518-5p/hsa-miR-3135b Regulates the REL/SOD2 Pathway in Ischemic Cerebral Infarction
por: Zhao, Boyan, et al.
Publicado: (2022)

Hsa-let-7c-5p, hsa-miR-130b-3p, and hsa-miR-142-3p as Novel miRNA Biomarkers for Melanoma Progression
por: Wu, Xuerui, et al.
Publicado: (2022)

miR-590-3p and Its Downstream Target Genes in HCC Cell Lines
por: Elfar, Mennatallah, et al.
Publicado: (2019)

Functional role and epithelial to mesenchymal transition of the miR-590-3p/MDM2 axis in hepatocellular carcinoma
por: Youssef, Alaa Ibrahem, et al.
Publicado: (2023)

Gestational Diabetes Mellitus Regulatory Network Identifies hsa-miR-145-5p and hsa-miR-875-5p as Potential Biomarkers
por: Zamanian Azodi, Mona, et al.
Publicado: (2019)

Qualitative and quantitative assessment of sperm miRNAs identifies hsa-miR-9-3p, hsa-miR-30b-5p and hsa-miR-122-5p as potential biomarkers of male infertility and sperm quality
por: Joshi, Meghali, et al.
Publicado: (2022)

MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1
por: Dai, Yao, et al.
Publicado: (2016)

MiR-590-3p promotes proliferation and metastasis of colorectal cancer via Hippo pathway
por: Sun, Zhen-Qiang, et al.
Publicado: (2017)

miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
por: Chen, Minjiang, et al.
Publicado: (2018)

Effect of LINC00657 on Apoptosis of Breast Cancer Cells by Regulating miR-590-3p
por: Shan, Qiuli, et al.
Publicado: (2020)

Exosomal miR-590-5p in Serum as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zheng, Guo-Dian, et al.
Publicado: (2021)

Identification of Circulating hsa-miR-324-3p and hsa-miR-331-3p Exchanges in The Serum of Alzheimer’s Patients and Insights into The Pathophysiological Pathways
por: Heydari, Maryam, et al.
Publicado: (2021)

Expression profiles of hsa-miR-148a-3p and hsa-miR-125b-5p in human breast milk and infant formulae
por: Chiba, Takeshi, et al.
Publicado: (2022)

Hsa-miR-27a-3p overexpression in men with nonobstructive azoospermia: A case-control study
por: Norioun, Hamid, et al.
Publicado: (2020)

Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17
por: Ma, Jinhua, et al.
Publicado: (2021)

The micro RNA hsa-miR-377-3p inhibits tumor growth in malignant melanoma
por: Yuan, Jian, et al.
Publicado: (2019)

Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer
por: Lopes, Camile B., et al.
Publicado: (2018)

Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma
por: Wang, Xiangkun, et al.
Publicado: (2019)

Hsa-miR-5581-3p and Hsa-miR-542-3p Target the F8 Gene in Hemophilia A without F8 Mutations
por: Meng, Feiying
Publicado: (2021)

Obese Asthma Phenotype Is Associated with hsa-miR-26a-1-3p and hsa-miR-376a-3p Modulating the IGF Axis
por: Gil-Martínez, Marta, et al.
Publicado: (2023)

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies
por: Chim, Chor Sang, et al.
Publicado: (2011)

Hsa_circ_0000994 Inhibits Pancreatic Cancer Progression by Clearing Immune-Related miR-27a and miR-27b
por: Liu, Jun, et al.
Publicado: (2022)

miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability
por: Liu, Ying, et al.
Publicado: (2023)

Identification of hsa-miR-619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma
por: Feng, Linxiang, et al.
Publicado: (2023)

Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
por: Mohd Yacob, Aliza, et al.
Publicado: (2022)

Hsa_circ_0060927 participates in the regulation of Caudatin on colorectal cancer malignant progression by sponging miR‐421/miR‐195‐5p
por: Chen, Juan, et al.
Publicado: (2022)

Blood hsa-miR-122-5p and hsa-miR-885-5p levels associate with fatty liver and related lipoprotein metabolism—The Young Finns Study
por: Raitoharju, Emma, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fm5rugvk8emhr9g6ktecges3uo